|Previous||1 of 1||Next|
small (250x250 max)
medium (500x500 max)
large ( > 500x500)
Oklahoma Immunization Update April 2013 PREVENTION and PREPAREDNESS SERVICES IMMUNIZATION SERVICE PLEASE POST & DISTRIBUTE TO ALL NURSING AND MEDICAL STAFF Celebrate National Infant Immunization Week - April 20-27, 2013 Join in the celebration of the life-saving power of vaccines April 20th through April 27th. National Infant Immunization Week (NIIW) is an annual observance to highlight the importance of protecting infants from vaccine-preventable diseases and celebrate the achievements of immunization programs and their partners in promoting healthy communities. Simple, easy ways to celebrate: · Provide vaccine information pamphlets to all parents · Post infographics that describe the risks of the diseases versus the risks of vaccines · Post vaccine posters · Check the records of all your patients less than 3 years of age and find out if they are up-to-date · Call the parents of those who are due or past due for vaccines and schedule an appointment Email the Immunization Service at email@example.com or call 800-234-6196 to order at no charge vaccine pamphlets, posters and infographics, and official immunization record cards to give to parents. Quick Responses to Parents Questions about Adolescent Vaccines Adolescents will soon be presenting for Tdap vaccine to meet the requirement for one dose of Tdap to enter the seventh grade in Oklahoma. Remember to recommend and offer HPV and MCV4 vaccines at the same visit. To help educate parents, here are some quick responses to questions they might ask. Quick responses to parents’ questions about HPV Why does my son or daughter need HPV vaccine at age 11 or 12? Why not wait until they are older? · The HPV vaccine works best at this age. We see a better immune response to this vaccine in adolescents 11 & 12 years of age. · The vaccine produces higher levels of antibodies that fight infection when given at this age compared to older ages. · We want to be sure that adolescents have this protection before they are exposed to the virus. · For the HPV vaccine to work best, it is very important for preteens to get all 3 doses (shots) long before any sexual activity with another person begins. Is HPV vaccine covered by insurance? · Some health insurance plans may not cover HPV vaccine. Check with your insurance provider to see if the cost of the vaccine is covered. If HPV vaccine is not covered by your insurance, your child can receive the vaccine at your local health department at no charge. For more advice, visit this CDC website: Tips and Time- Savers for Talking with Parents about HPV Vaccine at http://www.cdc.gov/vaccines/who/teens/for-hcp-tipsheet-hpv. html Quick responses to parents’ questions about MCV4: Why does my child need meningococcal vaccine? I never had this vaccine. · We didn’t have a vaccine to protect against this disease until 2005, but teens, pre-teens, and young adults are at increased risk. What is meningococcal disease? · Meningococcal disease is a rare, but dangerous bacterial infection that causes meningitis and blood stream infection. Why should I be concerned about meningococcal disease? · While meningococcal disease is rare, it can be very serious. · Meningococcal infection can spread quickly, killing an otherwise healthy person in 48 hours. · Even with the best treatment, 10 to 14 percent of people who become infected will die and 15 percent of survivors will suffer complications including brain damage, hearing loss, and amputations. Is meningococcal vaccine safe? Yes, MCV4 has been studied very carefully and is safe and effective. This vaccine, like any medicine, could possibly cause serious problems, such as severe allergic reactions. · About half of the people who get this vaccine have mild side effects, such as redness or pain where the shot was given. If these problems occur, they usually last 1 to 2 days. A few people who receive the vaccine develop a fever. · Serious allergic reactions, within a few minutes to a few hours of the shot, are very rare. A few cases of Guillain-Barré Syndrome (GBS), a serious nervous system disorder, have been reported among people who have received Menactra® vaccine. There is not enough evidence yet to tell whether any of these cases were caused by the vaccine or would have occurred even if the vaccine was not given. This is being investigated by health officials. All those who have become ill with GBS following Menactra immunization have recovered or are recovering. What is Guillain-Barré Syndrome? GBS is a serious, rare neurological disorder that can occur, often in healthy individuals, either spontaneously or after certain infections. GBS typically causes increasing weakness in the legs and arms that can be severe and require hospitalization. People who become ill with GBS usually make a full recovery. Acknowledgements: National Foundation for Infectious Diseases & Centers for Disease Control and Prevention (CDC) Find more MCV4 questions and answers at this CDC website: http://www.cdc.gov/vaccines/vpd-vac/ mening/who-vaccinate.htm. For an online version of this Update, visit the Immunization Service web page at: http://www.ok.gov/health/Disease,_Prevention,_Preparedness/Immunizations/Information_for_Health_Professionals/index.html. If you have any questions about this material, contact the Immunization Service by telephone at 405.271.4073 or by e-mail at firstname.lastname@example.org.
|Okla State Agency||
Health, Oklahoma State Department of
|Okla Agency Code||
|Title||Oklahoma immunization update, 04/2013|
Oklahoma. Immunization Service.
|Purpose||Celebrate National Infant Immunization Week - April 20-27, 2013; Quick Responses to Parents Questions about Adolescent Vaccines; Quick Responses to Parents Questions about HPV; Quick responses to parents' questions about MCV4|
|For all issues click||
|Digital Format||PDF, Adobe Reader required|
|ODL electronic copy||Downloaded from agency website: http://www.ok.gov/health2/documents/IMM_Update_2013_April.pdf|
|Rights and Permissions||This Oklahoma state government publication is provided for educational purposes under U.S. copyright law. Other usage requires permission of copyright holders.|